Jung Choi

2021

In 2021, Jung Choi earned a total compensation of $2.7M as Chief Business and Strategy Officer at Global Blood Therapeutics, a 54% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$179,000
Option Awards$1,102,132
Salary$460,000
Stock Awards$983,097
Other$6,000
Total$2,730,229

Choi received $1.1M in option awards, accounting for 40% of the total pay in 2021.

Choi also received $179K in non-equity incentive plan, $460K in salary, $983.1K in stock awards and $6K in other compensation.

Rankings

In 2021, Jung Choi's compensation ranked 4,806th out of 12,406 executives tracked by ExecPay. In other words, Choi earned more than 61.3% of executives.

ClassificationRankingPercentile
All
4,806
out of 12,406
61st
Division
Manufacturing
2,007
out of 5,492
64th
Major group
Chemicals And Allied Products
849
out of 2,368
64th
Industry group
Drugs
759
out of 2,089
64th
Industry
Pharmaceutical Preparations
542
out of 1,536
65th

Pay ratio

Jung Choi's Pay$2,730,229
Median Employee's Pay$345,973
Pay Ratio

8

to 1

In 2021, the annual total compensation of Jung Choi was $2,730,229.

The annual total compensation of the median employee at Global Blood Therapeutics was $345,973.

The ratio of Jung Choi's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 28, 2022.

Choi's colleagues

We found four more compensation records of executives who worked with Jung Choi at Global Blood Therapeutics in 2021.

2021

Ted Love

Global Blood Therapeutics

Chief Executive Officer

2021

Kim Smith-Whitley

Global Blood Therapeutics

EVP, Head of R&D

2021

Jeffrey Farrow

Global Blood Therapeutics

Chief Financial Officer

2021

David Johnson

Global Blood Therapeutics

Chief Commercial Officer

News

You may also like